Gastroenterology 2001; 120: 1522-1541.
98. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007; 357: 1731- 43.
99. Mandal AK, Mehdi I, Munshi SK. Value of routine duodenal biopsy in diagnosing coeliac disease in patients with iron deficiency anaemia. Postgrad Med J 2004; 80: 475–477
100.Howard MR, Turnbull AJ, Morley P, et al. A prospective study of the
prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J.
Clin. Pathol. 2002; 55; 754-757
101. Tatar G, Elsurer R, Simsek H, et al. Screening of tissue transglutaminase
antibody in healthy blood donors for Celiac Disease screening in the Turkish population. Dig Dis Sci 2004; 49: 1479-1484.
102. Tatar G, Elsurer R, Simsek H, et al. Screening of tissue transglutaminase antibody in healthy blood donors for Celiac Disease screening in the Turkish population. Dig Dis Sci 2004; 49: 1479-1484.
103. Fasano A, Berti I, Gerarduzzi T, Not T,et al. Prevalence of celiac disease in at-risk and notat-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003; 163:
286-292.
104. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-92.
105. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003;52:960-5.
106. Ivarsson A, Persson LA, Nystrom L, et al. Epidemic of coeliac disease in Swedish children. Acta Paediatr 2000;89:165-71.
107. Ivarsson A, Hernell O, Stenlund H, et al. Breast-feeding protects against celiac disease.
Am J Clin Nutr 2002;75:914-21.
108. Ertekin V, Selimoglu MA, Kardas F, et al. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol 2005;39:689-91
109. Tatar G, Elsurer R, Simsek H, et al. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci 2004;49:1479-84.
110. Crowe SE. Celiac Disease. In: DeLegge MH, editor. Clinical gastroenterology: Nutrition and gastrointestinal disease Totowa, N.J.: Humana Press; 2008. p. xii, 334 p.
111. Maki M, Kallonen K, Lahdeaho ML, et al. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr Scand 1988;77:408-12.
112. Sollid LM. Celiac Disease. In: Rose NR, Mackay IR, editors. The autoimmune diseases.
4th ed. Amsterdam ; Boston: Academic Press; 2006. p. xxv, 1134 p., [26] p. of col. plates.
113. Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr 1999;69:354-65.
114. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346:180-8.
115. Ciacci C, Cirillo M, Auriemma G, et al. Celiac disease and pregnancy outcome. Am J Gastroenterol 1996;91:718-22.
116. Sanders DS. Coeliac disease and subfertility: association is often neglected. BMJ 2003;327:1226- 7.
117. Cronin CC, Feighery A, Ferriss JB, et al. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol 1997;92:2210-2.
118. Collin P, Reunala T, Pukkala E, et al. Coeliac disease--associated disorders and survival.
Gut 1994;35:1215-8.
119. Collin P, Salmi J, Hallstrom O, et al. Autoimmune thyroid disorders and coeliac disease.
Eur J Endocrinol 1994;130:137-40.
120. Heneghan MA, Stevens FM, Cryan EM, et al. Celiac sprue and immunodeficiency states:
a 25- year review. J Clin Gastroenterol 1997;25:4215.
121. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for
autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117:297303.
122. Sategna Guidetti C, Solerio E, Scaglione N, et al. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 2001;49:502-5.
123. Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue.
Science 2002;297:2275-9.
124. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987;40:1-14.
125. Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50:624-8.
126. Anderson RP, Degano P, Godkin AJ, et al. In vivo antigen challenge in celiac disease identifies asingle transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
Nat Med 2000;6:337- 42.
127. Arentz-Hansen H, Korner R, Molberg O, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603-12
128. Shewry PR, Halford NG, Lafiandra D. Genetics of wheat gluten proteins. Adv Genet 2003;49:111-84.
129. Vader LW, Stepniak DT, Bunnik EM, et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003;125:1105-13.
130. Lundin KE, Nilsen EM, Scott HG, et al. Oats induced villous atrophy in coeliac disease.
Gut 2003;52:1649-52.
131. Arentz-Hansen H, Fleckenstein B, Molberg O, et al. The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 2004;1:e1.
132. Ivarsson A, Hernell O, Nystrom L, et al. Children born in the summer have increased risk for coeliac disease. J Epidemiol Community Health 2003;57:36-9.
133. Kagnoff MF, Austin RK, Hubert JJ, et al. Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 1984;160:1544-57.
134. Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology 2005;128:S10-8.
135. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005;129:1294-301.
136. Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue.
Science 2002;297:2275-9.
137. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
138. Schuppan D, Hahn EG. Biomedicine. Gluten and the gut-lessons for immune regulation.
Science 2002;297:2218-20.
139. Piper JL, Gray GM, Khosla C. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 2002;41:386-93.
140. Vader W, Kooy Y, Van Veelen P, et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002;122:1729-37.
141. Halttunen T, Maki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999;116:566-72.
142. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathyassociated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000;356:203-8.
143. Rodrigo L.Celiac disease. World J Gastroenterol. 2006; 7: 6585-93
144. Kagalwalla AF, Shah A, Ritz S, et al. Cow's milk protein-induced eosinophilic esophagitis in a child with gluten-sensitive enteropathy. J Pediatr Gastroenterol Nutr 2007;44:386-8.
145. Kristjansson G, Venge P, Hallgren R. Mucosal reactivity to cow's milk protein in coeliac disease. Clin Exp Immunol 2007;147:449-55.
146. Shamir R. Advances in celiac disease. Gastroenterol Clin North Am 2003;32:931-47.
147. Jores RD, Frau F, Cucca F, et al. HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. Scand J Gastroenterol 2007;42:48-53.
148. Ciclitira PJ, King AL, Fraser JS. AGA technical review on Celiac Sprue. American Gastroenterological Association. Gastroenterology 2001;120:1526-40.
149. Locke GR, 3rd, Murray JA, Zinsmeister AR, et al. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc 2004;79:476-82.
150.Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int J Biochem Cell Biol.2004; 36: 17-24.
151. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A
molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’).
Gastroenterology. 1992; 102: 330-354.
152. Yachha SK, Poddar U.Celiac disease in India. Indian J Gastroenterol. 2007; 26: 230-7.
153.Sategna-Guidetti C, Grosso S, Bruno M, Grosso SB. Reliability of immunologic markers of celiac sprue in the assessment of mucosal recovery after gluten withdrawal. J Clin
Gastroenterol. 1996; 23:101-4.
154. A. Fasano, C. Catassi Current Approaches to Diagnosis and Treatment of CeliacDisease:
An Evolving Spectrum Gastroenterology, Volume 120(3):636 651
155. Parnell ND, Ciclitira PJ. Review Article: coeliac disease and its management.Aliment Pharmacol Ther 1999; 13: 1-13.
156. Ebru Uz, Cansel Türkay Çölyak hastalığı Güncel Gastroenteroloji eylül 2006:214-224 157. Farrell RJ, Kelly CP. Celiac Sprue and Refractory sprue. In: Feldman M,
Scharschmidt BF, Sleissenger MH. Gastrointestinal and Liver Disease., Philadelphia:
Saunders Co, 2006 8th. Ed.; 2277-2307
158. Scott H, Fausa O, Ek J, Valnes K, Blystad L, Brandtzaeg P Measurements of serum IgA and IgG activities to dietary antigens: A prospective study of the
diagnostic usefulness in adult coeliac disease Scand. J. Gastroenterol. 1990;25(3):287-292.
159. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, Fasano A.
Coeliac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998; 33: 494-498
160. Kapuscinska Alicja, Zalewski Tadeusz, Chorzelski Tadeusz P, Sulej Jadwiga, Buetner Ernst H, Kumar Vijay et. al Disease specificity and dynamics of changes in IgA class anti-endomysial antibodies in celiac disease. J Pediatr Gastroenterolgy Nutr 1987; 6: 529-534 161. Yardley, John H., Dubois, Raymond N., Lazenby, Audrey J., Hendrix, Thomas R., Bayless, Theodore M., Giardiello, Francis M Lymphocytic enteroclitis in patients with
“refractory sprue.” JAMA 1989;262:935-937
162. Ahmet Erdil, Yüksel Ateş Gluten Enteropatisinde Son Gelişmeler Güncel Gastroenteroloji dergisi mart 2005 sayı:9/1:18-28
163. Gren PH, Murray JA. Routine duodenal biopsies to exclude celiac disease?
Gastrointestinal Endoscopy 2003; 58:92-95
164.Peräaho M, Kaukinen K, Mustalahti K, Vuolteenaho N, et al. Effect of an oats-containing glutenfree diet on symptoms and quality of life in coeliac disease: a randomized study. Scand J Gastroenterol. 2004; 39: 27-31.
165.Ojetti V, Nucera G, Migneco A, Gabrielli M, et al. High prevalence of celiac disease in patients with lactose intolerance. Digestion. 2005; 71: 106-110.
166.Green PH, Cellier C.Celiac disease.N Engl J Med. 2007; 357: 1731- 43.
167. Pink IJ, Creamer B. Response to a gluten-free diet of patients with the coeliac syndrome.
Lancet 1967; 1: 300-304
168. J M Grefte, J G Bouman, J Grond, W Jansen, J H Kleibeuker Slow and
incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988; 41: 886-891.
169. Haubrich WS, Schaffner F, Berk JE (eds): Bockus Gastroenterology, 5th . Philadelphia: WB Saunders, 1995. Chapter 59 :1027-1046
170. H. Gillett, I. Arnott, M. McIntyre, S. Campbell, A. Dahele, M. Priest, R.
Jackson, S. Ghosh Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002; 122: 800-805
171. Robins Gery G, Howdle Peter D Recent advences in celiac disease Current opinion in gastroenterology 2009 vol25(2):100-109
172. Per Brandtzaeg. The changing immunological paradigm in coeliac disease Immunology Letters. 2006;105:127–139
173. G.Corrao, G.Corazza, V.Bagnardi, G.Brusco, C.Ciacci, M.Cottone, C.Guidetti, P.Usai, P.Cesari, M.Pelli Mortality in patients with coeliac disease and their relatives: a cohort study Lancet 2001; 358:356-361.
174. Picarelli A, di Tola M, Sabbatella L, et al. Identification of a new coeliac disease
subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency. J Intern Med 2001;249:181-8.
175. Dahele AV, Aldhous MC, Humphreys K, et al. Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases. QJM 2001;94:195-205.
176. West J, Lloyd CA, Hill PG, et al. IgA-antitissue transglutaminase: validation of a commercial assay for diagnosing coeliac disease. Clin Lab 2002;48:241-6.
177. Güçlü M, Serin E. Mikroskopik kolit. Güncel Gastroenteroloji 2004; 104 110 178. Rams H, Rogers AI, Ghandur-Mnaymneh L. "Collagenous colitis, clinical review" Ann. Int. Med. 1987; 106: 108-13.
179. Limsui D, Pardi DS, Camilleri M, et al. Symptomatic overlap between
irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007; 13(2): 175-81.
180. Drossman DA. Irritable bowel syndrome. The Functional Gastrointestinal Disorders. 2 nd ed. In: Drossman DA, Talley NJ, Thompson WG, Whitead WE (eds), Philadelphia 2001; 355-75.
181. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002
Jun;122(7):1778-83.
182. Madisch A, Bethke B, Stolte M, Miehlke S. Is there an association of microscopic colitis and irritable bowel syndrome--a subgroup analysis of placebo-controlled trials. World J Gastroenterol 2005 Nov 7;11(41):6409.
183. Erdem L, Yildirim S, Akbayir N, Yilmaz B, Yenice N, Gultekin OS, et al. Prevalence of microscopic colitis in patients with diarrhea of unknown etiology in Turkey. World J
Gastroenterol 2008 Jul 21;14(27):4319-23.
184. Tunçer C, Cindoruk M, Dursun A, et al Prevalence of microscopic colitis in
patients with symptoms suggesting irritable bowel syndrome. Acta Gastroenterol Belg. 2003 Apr-Jun; 66(2): 133-6.
185. MacIntosh DG, Thompson WG, Patel DG, et al. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol. 1992 Oct; 87(10): 1407-9.